Trial Profile
A perioperative, single-arm multicenter Phase II academic trial to investigate the efficacy and safety of panitumumab in combination with irinotecan/5-fluorouracil/leucovorin in patients with previously untreated, wild-type KRAS, potentially resectable colorectal cancer liver metastases
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Dec 2020
Price :
$35
*
At a glance
- Drugs Fluorouracil (Primary) ; Folinic acid (Primary) ; Folinic acid (Primary) ; Irinotecan (Primary) ; Panitumumab (Primary)
- Indications Colorectal cancer; Liver metastases
- Focus Adverse reactions; Therapeutic Use
- 31 May 2020 Status changed from recruiting to completed.
- 31 May 2020 Results presented at the 56th Annual Meeting of the American Society of Clinical Oncology.
- 29 Jun 2012 New trial record